Published in Biochem Biophys Res Commun on October 27, 2010
Mesenchymal stem cells in tumor development: emerging roles and concepts. Cell Adh Migr (2012) 1.24
Tracking intracavernously injected adipose-derived stem cells to bone marrow. Int J Impot Res (2011) 0.99
Adipose tissue-derived stem cells ameliorate diabetic bladder dysfunction in a type II diabetic rat model. Stem Cells Dev (2011) 0.94
Correction of diabetic erectile dysfunction with adipose derived stem cells modified with the vascular endothelial growth factor gene in a rodent diabetic model. PLoS One (2013) 0.94
Effects of EdU labeling on mesenchymal stem cells. Cytotherapy (2013) 0.92
Stem cells: novel players in the treatment of erectile dysfunction. Asian J Androl (2011) 0.86
Prospects of stem cell treatment in benign urological diseases. Korean J Urol (2015) 0.85
The regulation of inflammatory mediators in acute kidney injury via exogenous mesenchymal stem cells. Mediators Inflamm (2014) 0.82
Sexual dysfunction: The potential of stem cell therapy for Peyronie disease. Nat Rev Urol (2012) 0.76
Treatment of diabetes mellitus-induced erectile dysfunction using endothelial progenitor cells genetically modified with human telomerase reverse transcriptase. Oncotarget (2016) 0.75
Therapeutic potential of ixmyelocel-T, an expanded autologous multicellular therapy for treatment of ischemic cardiovascular diseases. Stem Cell Res Ther (2015) 0.75
Adipose tissue as an endocrine organ. Mol Cell Endocrinol (2009) 5.20
Multipotential differentiation of adipose tissue-derived stem cells. Keio J Med (2005) 3.28
Defining stem and progenitor cells within adipose tissue. Stem Cells Dev (2008) 2.63
Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer. J Clin Invest (1998) 2.42
Obesity, inflammation, and cardiovascular risk. Clin Pharmacol Ther (2010) 2.06
Adipose tissue macrophages. Immunol Lett (2007) 2.02
Treatment of erectile dysfunction in the obese type 2 diabetic ZDF rat with adipose tissue-derived stem cells. J Sex Med (2010) 1.99
Defining adipose tissue-derived stem cells in tissue and in culture. Histol Histopathol (2010) 1.95
The adipose-derived stem cell: looking back and looking ahead. Mol Biol Cell (2010) 1.78
The obesity epidemic. Clin Chest Med (2009) 1.74
Treatment of stress urinary incontinence with adipose tissue-derived stem cells. Cytotherapy (2010) 1.71
Adipose tissue derived stem cells secretome: soluble factors and their roles in regenerative medicine. Curr Stem Cell Res Ther (2010) 1.70
CXC ligand 5 is an adipose-tissue derived factor that links obesity to insulin resistance. Cell Metab (2009) 1.68
The effect of intracavernous injection of adipose tissue-derived stem cells on hyperlipidemia-associated erectile dysfunction in a rat model. J Sex Med (2010) 1.50
Secretome of primary cultures of human adipose-derived stem cells: modulation of serpins by adipogenesis. Mol Cell Proteomics (2006) 1.37
Adipose stromal cells stimulate angiogenesis via promoting progenitor cell differentiation, secretion of angiogenic factors, and enhancing vessel maturation. Tissue Eng Part A (2009) 1.36
CXC-chemokine/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancer. Int J Cancer (2009) 1.25
Adipose derived stem cells ameliorate hyperlipidemia associated detrusor overactivity in a rat model. J Urol (2010) 1.17
Adipose tissue-derived stem cells secrete CXCL5 cytokine with neurotrophic effects on cavernous nerve regeneration. J Sex Med (2010) 1.16
Time to abandon dogma: CD14 is expressed by non-myeloid lineage cells. Immunol Cell Biol (2005) 1.14
Adipose tissue: a motor for the inflammation associated with obesity. IUBMB Life (2009) 1.12
Elevated serum chemokine CXC ligand 5 levels are associated with hypercholesterolemia but not a worsening of insulin resistance in Chinese people. J Clin Endocrinol Metab (2010) 1.03
Local transplantation of human multipotent adipose-derived stem cells accelerates fracture healing via enhanced osteogenesis and angiogenesis. Lab Invest (2010) 1.01
Lack of direct androgen regulation of PDE5 expression. Biochem Biophys Res Commun (2009) 0.89
American Urological Association guideline on the management of priapism. J Urol (2003) 3.77
Defining stem and progenitor cells within adipose tissue. Stem Cells Dev (2008) 2.63
Molecular mechanisms related to parturition-induced stress urinary incontinence. Eur Urol (2008) 2.17
Treatment of erectile dysfunction in the obese type 2 diabetic ZDF rat with adipose tissue-derived stem cells. J Sex Med (2010) 1.99
Correction of penile curvature using the 16-dot plication technique: a review of 132 patients. J Urol (2002) 1.96
Defining adipose tissue-derived stem cells in tissue and in culture. Histol Histopathol (2010) 1.95
Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: pathophysiology and mechanism(s) of action. Neurourol Urodyn (2011) 1.93
Injections of adipose tissue-derived stem cells and stem cell lysate improve recovery of erectile function in a rat model of cavernous nerve injury. J Sex Med (2010) 1.87
Physiology of penile erection and pathophysiology of erectile dysfunction. Urol Clin North Am (2005) 1.81
RNAa is conserved in mammalian cells. PLoS One (2010) 1.81
Neuron-like differentiation of adipose tissue-derived stromal cells and vascular smooth muscle cells. Differentiation (2006) 1.73
Treatment of stress urinary incontinence with adipose tissue-derived stem cells. Cytotherapy (2010) 1.71
T-shaped shunt and intracavernous tunneling for prolonged ischemic priapism. J Urol (2009) 1.69
Upregulation of penile brain-derived neurotrophic factor (BDNF) and activation of the JAK/STAT signalling pathway in the major pelvic ganglion of the rat after cavernous nerve transection. Eur Urol (2006) 1.67
Brain activation and sexual arousal in healthy, heterosexual males. Brain (2002) 1.62
Complications of porcine small intestine submucosa graft for Peyronie's disease. J Urol (2007) 1.57
Chapter 1: The management of erectile dysfunction: an AUA update. J Urol (2005) 1.55
Penile sonographic and clinical characteristics in men with Peyronie's disease. J Sex Med (2009) 1.55
Psychological impact of erectile dysfunction: validation of a new health related quality of life measure for patients with erectile dysfunction. J Urol (2002) 1.54
The effect of intracavernous injection of adipose tissue-derived stem cells on hyperlipidemia-associated erectile dysfunction in a rat model. J Sex Med (2010) 1.50
Differential dynamical effects of macromolecular crowding on an intrinsically disordered protein and a globular protein: implications for in-cell NMR spectroscopy. J Am Chem Soc (2008) 1.49
Erection of the human penis and its morphological and vascular basis by Guiseppe Conti. J Sex Med (2008) 1.45
Labeling and tracking of mesenchymal stromal cells with EdU. Cytotherapy (2009) 1.45
Effects of high glucose on human cavernous endothelial cells. Urology (2012) 1.44
Stem cell therapy for erectile dysfunction: a critical review. Stem Cells Dev (2011) 1.44
Allogeneic and xenogeneic transplantation of adipose-derived stem cells in immunocompetent recipients without immunosuppressants. Stem Cells Dev (2012) 1.44
Improving erectile function by silencing phosphodiesterase-5. J Urol (2005) 1.43
Cavernous nerve repair with allogenic adipose matrix and autologous adipose-derived stem cells. Urology (2011) 1.43
Summary of the recommendations on sexual dysfunctions in men. J Sex Med (2010) 1.42
The effect of neural embryonic stem cell therapy in a rat model of cavernosal nerve injury. BJU Int (2004) 1.37
Fibroblast growth factor 2 promotes endothelial differentiation of adipose tissue-derived stem cells. J Sex Med (2008) 1.35
A pathophysiology-based approach to the management of early priapism. Asian J Androl (2012) 1.35
Anatomy, physiology, and pathophysiology of erectile dysfunction. J Sex Med (2010) 1.35
T-shunt with or without tunnelling for prolonged ischaemic priapism. BJU Int (2008) 1.33
Effects of low-energy shockwave therapy on the erectile function and tissue of a diabetic rat model. J Sex Med (2012) 1.30
Multiple conformations of phosphodiesterase-5: implications for enzyme function and drug development. J Biol Chem (2006) 1.29
AUA guideline on the pharmacologic management of premature ejaculation. J Urol (2004) 1.28
An animal model to study lower urinary tract symptoms and erectile dysfunction: the hyperlipidaemic rat. BJU Int (2007) 1.27
Phosphodiesterase type 5 inhibitors for erectile dysfunction. BJU Int (2005) 1.24
Peyronie's disease (CME). J Sex Med (2007) 1.24
Up-regulation of estrogen responsive genes in hypospadias: microarray analysis. J Urol (2007) 1.23
CHIP controls the sensitivity of transforming growth factor-beta signaling by modulating the basal level of Smad3 through ubiquitin-mediated degradation. J Biol Chem (2005) 1.21
Expression, distribution and regulation of phosphodiesterase 5. Curr Pharm Des (2006) 1.20
Label retaining and stem cell marker expression in the developing rat urinary bladder. Urology (2011) 1.19
Stem cell therapy for stress urinary incontinence: a critical review. Stem Cells Dev (2012) 1.18
Adipose derived stem cells ameliorate hyperlipidemia associated detrusor overactivity in a rat model. J Urol (2010) 1.17
Recruitment of intracavernously injected adipose-derived stem cells to the major pelvic ganglion improves erectile function in a rat model of cavernous nerve injury. Eur Urol (2011) 1.17